Adenosine 3',5'-cyclic monophosphate sodium salt:Exports & Compliance White Paper 2026

I. Executive Summary

Adenosine 3',5'-cyclic monophosphate sodium salt (CAS 37839-81-9), the sodium salt of cyclic adenosine monophosphate (cAMP), holds a narrow but strategically important position in the global research-reagent supply chain. It is the canonical second messenger used to interrogate cAMP-dependent signalling in vitro, and it is purchased almost exclusively by academic laboratories, CROs, assay-kit manufacturers and biotech process-development groups. As supplied by manufacturers and distributors, this material is Research Use Only (RUO). It has no approved therapeutic indication, it is not a finished medicinal product, and it is not a consumer, food or dietary product. Any offer, listing or dossier that implies diagnostic or therapeutic use is a compliance failure, not a marketing choice.

Commercially, the differentiating variables are not price but specification discipline: the water of crystallisation of the hydrate, the sodium counter-ion assay, the related-substance profile (principally 5'-AMP and free adenosine arising from hydrolysis or incomplete cyclisation), residual solvent and inorganic salt load, and - for molecular-biology grades - endotoxin, bioburden and DNase/RNase-free status. Buyers increasingly request a full certificate of analysis with chromatogram, a validated stability-indicating HPLC method, and a declaration of the route class used, because nucleotide salts are hygroscopic and the hydrate form drifts if packaging or cold chain is weak.

For sourcing managers the practical message is to treat CAS 37839-81-9 as a CDMO-managed project material rather than a catalogue commodity. Define the grade (RUO versus ISO 9001 or GMP-aligned campaign), lock the hydrate specification and water-content method, fix the packaging configuration with desiccant and amber barrier, and secure a cold-chain lane with documented temperature excursion handling before the first shipment. Suppliers able to offer route transparency, method validation and reference-material documentation capture the higher-value repeat business.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

cAMP is adenosine in which a single phosphate diester bridges the 3'- and 5'-hydroxyls of the ribose, forming a six-membered cyclic phosphate ring. The free acid has the formula C10H12N5O6P (relative molecular mass 329.21); the monosodium salt is C10H11N5NaO6P, and commercial lots are usually supplied as a hydrate. The cyclic phosphate removes one ionisable proton relative to a monoester, so the molecule carries a single negative charge and one sodium counter-ion across the physiological pH range, and that charge state governs both its chromatographic behaviour and its very high aqueous solubility.

• Conformational lock and recognition: the 3',5'-cyclic phosphate restrains the ribose and fixes the base in a presentation recognised by the cyclic-nucleotide-binding domains of protein kinase A regulatory subunits, Epac/GEF proteins, cyclic-nucleotide-gated channels and phosphodiesterases. This is why the cyclic isomer behaves as a signalling ligand while the linear 5'-AMP does not, and why the related-substance limit for 5'-AMP is a genuine performance specification rather than a cosmetic one.
• Identity, spectroscopy and stability: the adenine chromophore gives a UV maximum near 259 nm with a molar absorptivity of roughly 15,000 L/mol/cm, which underpins both HPLC-UV assay and concentration checks in the laboratory. The solid is a white to off-white crystalline or lyophilised powder, freely soluble in water and practically insoluble in most organic solvents; the cyclic diester hydrolyses under strongly acidic or alkaline conditions and is cleaved by phosphodiesterase activity, so solution stability and container hygiene are specification-relevant.

2.2 Synthesis and Manufacturing Technologies

Two route families dominate legitimate industrial supply, and mature programmes run both depending on the required grade. In each case the sodium salt and hydrate form are set deliberately in the final isolation step, not left to chance, because the counter-ion and water content are the first items a buyer's QC laboratory will challenge.

• Enzymatic and fermentation-derived routes: adenylate cyclase biotransformation converts fermentation-derived ATP to cAMP in a single aqueous step, giving excellent regiospecificity and avoiding phosphoryl chloride chemistry. Downstream processing typically combines enzyme removal or immobilised-enzyme operation, activated-carbon or resin decolourisation, and ion-exchange capture. This class is preferred where endotoxin, DNase/RNase-free requirements and a clean impurity profile matter.
• Chemical cyclodehydration and chromatographic polishing: the classical alternative cyclises adenosine or a 5'-nucleotide using carbodiimide-mediated intramolecular dehydration or a phosphorylating agent in an aprotic solvent system, followed by quenching, neutralisation to the sodium form and purification by anion-exchange and preparative reversed-phase or ion-pair HPLC. It scales predictably but generates inorganic salt and solvent load, so ICH Q3C residual-solvent and Q3D elemental-impurity thinking is applied even for RUO material.

2.3 Core Application Matrix

• Cell-signalling and second-messenger research: used in vitro as a pathway agonist or calibrator in cAMP accumulation, PKA activation, CREB reporter and phosphodiesterase assays, and in GPCR screening campaigns run by pharmaceutical and CRO laboratories. Supply is consumed in milligram-to-gram quantities but with demanding lot-to-lot consistency.
• Assay-kit manufacture and analytical standards: incorporated by diagnostics and life-science reagent manufacturers into HTRF, AlphaScreen, ELISA and luminescence cAMP assay kits, and used as an assay calibrator, system-suitability standard or spiking reference. These customers buy against written specifications and often require ISO 17034-aligned reference-material documentation and ISO/IEC 17025-calibrated methods.
• Nucleotide-analogue process development: serves as a starting material or comparative standard in custom-synthesis programmes for cyclic-nucleotide analogues and prodrugs, where the CDMO provides route scouting, analytical method development and non-GMP-to-GMP scale-up under confidentiality.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand tracks research spending rather than industrial consumption: GPCR drug discovery, immuno-oncology and cell-therapy programmes all use cAMP measurement as a functional read-out, and the growth of outsourced screening at CROs has shifted purchasing from individual laboratories to centralised procurement teams that qualify vendors once and then buy repeatedly. Kit manufacturers and reagent repackers now absorb a rising share of volume and negotiate annual contracts, which pushes suppliers toward documented change control, lot reservation and scheduled campaigns instead of spot production.

3.2 Capacity Distribution and Export Flows

Nucleotide fermentation and enzymatic-conversion capacity is concentrated in China and Japan, with China supplying both bulk nucleotide intermediates and finished RUO-grade cAMP sodium salt, and Japan retaining high-purity biochemical-reagent capability built on decades of nucleotide fermentation know-how. North America and Europe hold comparatively small synthesis footprints but dominate distribution, branding, kit integration and reference-material certification, so the physical trade flow runs East-to-West while the specification and documentation flow runs West-to-East.

3.3 Market Bifurcation and Pricing Dynamics

The market splits sharply into catalogue RUO material sold in vials at high unit price, and project volumes produced under ISO 9001 or GMP-aligned quality systems where price per gram falls but qualification cost rises. Hydrate versus lyophilised form, molecular-biology grade with nuclease and endotoxin limits versus general laboratory grade, and the presence or absence of a reference-material certificate each create distinct price tiers, and the spread between tiers is far wider than any movement in raw adenosine or ATP cost.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

Because the material is supplied RUO, the regulatory burden sits on chemical-inventory and workplace rules rather than on marketing authorisation. Nevertheless, the commercial perimeter is strict: no therapeutic or diagnostic claim may be attached to a RUO biochemical, and the dossier must also address the impurity and microbiology questions that buyers apply internally.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH (EC) 1907/2007: importers must confirm registration, PPORD or applicable exemption status and tonnage band for the exact substance before placing material on the EU market, because nucleotides and their salts are not automatically outside scope. Only Representatives, lead-registrant letters of access and up-to-date SDS authoring are the practical gateways for Chinese producers exporting to EU customers.
• CLP (EC) 1272/2008 and quality-system framing: suppliers should issue a current SDS and clearly non-hazardous or correctly classified labelling, keep the RUO statement on label, CoA and website, and align quality documentation with ISO 9001, with ISO 17034 and ISO/IEC 17025 framing when the lot is sold as a reference or analytical standard.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA inventory status: commercial import into the United States requires a positive inventory or exemption position for the substance as imported, documented in the import filing and supported by a supplier letter. Research and development quantities may be handled under the R&D exemption, but the paperwork must exist before the shipment moves.
• FDA perimeter and upgrade path: cAMP sodium salt supplied as RUO is not an approved drug, has no approved therapeutic indication, and must not be labelled or promoted for diagnostic or therapeutic use; where a customer requires material for regulated work, the supplier moves to a GMP-aligned campaign applying ICH Q7 and Q11 principles, with ICH Q1A stability and Q3D elemental-impurity assessment.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

ESG pressure on biochemical reagents arrives through customer procurement questionnaires rather than through legislation. Assay-kit manufacturers and pharmaceutical buyers now ask for solvent-reduction commitments, energy disclosures and waste-water treatment data, and suppliers who cannot answer lose tender slots even when their chemistry is sound.

5.1 Carbon Footprint and Circular Economy

The carbon profile of cAMP sodium salt is dominated less by the reaction than by isolation and distribution: preparative HPLC and lyophilisation are energy-intensive, fermentation downstream processing consumes steam and large water volumes, and refrigerated or frozen air freight multiplies the footprint per gram. Credible programmes report Scope 1 and 2 energy, measure Scope 3 logistics emissions, and reduce solvent load through aqueous enzymatic conversion and resin-based capture instead of large-volume solvent chromatography.

5.2 Sustainable Sourcing and Traceability

Buyers increasingly require an animal-origin-free and non-GMO statement for the adenosine or ATP feedstock, ISO 14001-certified sites, and documented waste-water treatment for phosphate-containing streams. Traceability also means analytical traceability: retained samples, a documented lot genealogy from nucleotide feedstock to finished vial, and a certificate that identifies the route class, counter-ion and hydrate form, so that any future investigation can be closed quickly.

VI. Supply Chain Resilience and Export Logistics

Nucleotide salts are hygroscopic solids whose value is destroyed by moisture ingress and by repeated freeze-thaw handling, so logistics design is a quality function, not a freight-afterthought. The commercial specification must therefore be written together with the packaging bill of materials and the temperature lane.

6.1 Packaging Standards and Moisture/Contamination Control

• Desiccated amber barrier pack: amber glass or high-barrier HDPE vials with PTFE-lined closures, secondary heat-sealed foil pouch with desiccant and humidity indicator, and nitrogen or dry-air headspace for hygroscopic hydrate grades. Assay, water content and appearance must be tested on retention samples from the actual commercial pack, not from a bulk drum.
• Molecular-biology-grade handling: for DNase/RNase-free and low-endotoxin lots, use certified nuclease-free containers, depyrogenated glassware where applicable, documented gowning and environmental monitoring, and avoid re-packing; bulk-to-vial subdivision is the single largest contamination risk and should be validated rather than assumed.

6.2 Dangerous Goods Identification and Transit Protocols

cAMP sodium salt is generally shipped as non-hazardous for transport, but the cooling regime creates its own regulated elements: dry ice is UN1845, Class 9, and air shipments must follow IATA packing instruction 954 with correct net-mass marking, while gel-pack refrigerated lanes need validated 2-8 °C qualification for the lane and season. Frozen shipments should specify -20 °C, define acceptable excursions, use data loggers with a documented excursion investigation procedure, and avoid ADR or IMO complications by confirming the SDS transport section for every lot before booking.

VII. Enterprise Global Expansion Strategy Guide

Suppliers entering Western RUO channels win through documentation discipline and service responsiveness rather than through price leadership. The following three moves are the ones that change qualification outcomes in practice.

1. Run a dual-track grade architecture: keep a fast RUO catalogue line with vialed inventory and a separate ISO 9001 or GMP-aligned campaign line with change control, validation protocols and reserved capacity, so that a customer's programme can escalate grade without changing supplier.
2. Sell the analytical dossier, not only the salt: offer a validated stability-indicating HPLC assay, LC-MS identity confirmation, NMR where required, Karl Fischer and sodium counter-ion assay, related-substance limits for 5'-AMP and adenosine, and optional endotoxin, bioburden and nuclease testing, all reported on a CoA with chromatograms.
3. Institutionalise KYC, confidentiality and tech transfer: operate documented end-use declaration, refuse non-qualified or consumer-directed orders under a written policy, protect custom routes with mutual NDA and segregated campaign records, and provide a structured tech-transfer package to the customer's receiving laboratory.

VIII. Conclusion

Adenosine 3',5'-cyclic monophosphate sodium salt is a specification-driven research material whose commercial value is created downstream of the chemistry: in hydrate and counter-ion control, in related-substance and endotoxin discipline, in cold-chain execution and in the credibility of the RUO perimeter. Suppliers who present it as a commodity salt compete on price and lose on qualification; suppliers who present it as a managed biochemical with a validated method set and a documented quality system build multi-year relationships with CROs, kit manufacturers and biotech customers.

Through 2026 the decisive capabilities will be enzymatic route competence, ISO 9001 with optional ISO 17034 reference-material framing, refrigerated and frozen logistics reliability, and the willingness to say no to non-qualified end uses. Those four elements, rather than nominal capacity, determine who participates in the higher-value tiers of this market.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global Adenosine 3',5'-cyclic monophosphate sodium salt Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Adenosine 3',5'-cyclic monophosphate sodium salt supply chain:

• China - nucleotide fermentation and export manufacturing: Chinese producers combine fermentation-derived adenosine and ATP with enzymatic cyclisation and resin or preparative-HPLC polishing, exporting RUO vials and kilogram-scale project lots to North America and Europe. Differentiated players hold ISO 9001, operate dedicated low-bioburden finishing rooms and supply CoAs with chromatograms, but buyers must still audit water-content method and change-control practice directly.
• United States - distribution, kit integration and reference materials: the US ecosystem is anchored by life-science reagent houses, catalog distributors and assay-kit manufacturers that define specifications, hold vendor qualification files and repack under their own brand. Demand is specification-led, ISO 17034-aligned reference documentation is increasingly requested, and TSCA inventory confirmation is a precondition of import.
• European Union - reagent branding, RUO compliance and cold-chain logistics: EU participants concentrate on regulatory framing, SDS and CLP authoring, RUO labelling discipline and temperature-controlled distribution hubs serving academic and pharmaceutical customers. REACH status verification and Only Representative support decide whether a non-EU producer can supply the region continuously rather than intermittently.